These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17616674)

  • 41. Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy.
    Osipo C; Gajdos C; Cheng D; Jordan VC
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):249-56. PubMed ID: 15860267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma.
    Kang J; Qian PX; Pandey V; Perry JK; Miller LD; Liu ET; Zhu T; Liu DX; Lobie PE
    Oncogene; 2010 Jun; 29(22):3228-40. PubMed ID: 20305694
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells.
    Howlin J; Rosenkvist J; Andersson T
    Breast Cancer Res; 2008; 10(2):R36. PubMed ID: 18435854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural insights into the association between BCAR3 and Cas family members, an atypical complex implicated in anti-oestrogen resistance.
    Garron ML; Arsenieva D; Zhong J; Bloom AB; Lerner A; O'Neill GM; Arold ST
    J Mol Biol; 2009 Feb; 386(1):190-203. PubMed ID: 19103205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas.
    van der Flier S; Chan CM; Brinkman A; Smid M; Johnston SR; Dorssers LC; Dowsett M
    Int J Cancer; 2000 Sep; 89(5):465-8. PubMed ID: 11008210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.
    van Agthoven T; Sieuwerts AM; Meijer-van Gelder ME; Look MP; Smid M; Veldscholte J; Sleijfer S; Foekens JA; Dorssers LC
    J Clin Oncol; 2009 Feb; 27(4):542-9. PubMed ID: 19075277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer.
    Joffroy CM; Buck MB; Stope MB; Popp SL; Pfizenmaier K; Knabbe C
    Cancer Res; 2010 Feb; 70(4):1314-22. PubMed ID: 20145137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional roles of BCAR3 in the signaling pathways of insulin leading to DNA synthesis, membrane ruffling and GLUT4 translocation.
    Oh MJ; Yi SJ; Kim HS; Kim JH; Jeong YH; van Agthoven T; Jhun BH
    Biochem Biophys Res Commun; 2013 Nov; 441(4):911-6. PubMed ID: 24216110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estrogen receptor regulates E2F1 expression to mediate tamoxifen resistance.
    Louie MC; McClellan A; Siewit C; Kawabata L
    Mol Cancer Res; 2010 Mar; 8(3):343-52. PubMed ID: 20215421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant.
    Fan M; Yan PS; Hartman-Frey C; Chen L; Paik H; Oyer SL; Salisbury JD; Cheng AS; Li L; Abbosh PH; Huang TH; Nephew KP
    Cancer Res; 2006 Dec; 66(24):11954-66. PubMed ID: 17178894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer.
    Chu I; Blackwell K; Chen S; Slingerland J
    Cancer Res; 2005 Jan; 65(1):18-25. PubMed ID: 15665275
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes.
    Pavanelli AC; Mangone FR; Yoganathan P; Bessa SA; Nonogaki S; de Toledo Osório CAB; de Andrade VP; Soares IC; de Mello ES; Mulligan LM; Nagai MA
    Breast Cancer Res Treat; 2022 Feb; 192(1):43-52. PubMed ID: 35031902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Essential role of SH3GL1 in interleukin-6(IL-6)- and vascular endothelial growth factor (VEGF)-triggered p130
    Li EQ; Zhang JL
    Hum Cell; 2017 Oct; 30(4):300-310. PubMed ID: 28702842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NEDD9 and BCAR1 negatively regulate E-cadherin membrane localization, and promote E-cadherin degradation.
    Tikhmyanova N; Golemis EA
    PLoS One; 2011; 6(7):e22102. PubMed ID: 21765937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cas proteins: dodgy scaffolding in breast cancer.
    Tornillo G; Defilippi P; Cabodi S
    Breast Cancer Res; 2014; 16(5):443. PubMed ID: 25606587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CAS proteins in normal and pathological cell growth control.
    Tikhmyanova N; Little JL; Golemis EA
    Cell Mol Life Sci; 2010 Apr; 67(7):1025-48. PubMed ID: 19937461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells.
    Cunningham-Edmondson AC; Hanks SK
    Breast Cancer (Dove Med Press); 2009; 1():39-52. PubMed ID: 24367162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Breast Cancer Antiestrogen Resistance 3 (BCAR3) promotes tumor growth and progression in triple-negative breast cancer.
    Arras J; Thomas KS; Myers PJ; Cross AM; Osei AD; Vazquez GE; Atkins KA; Conaway MR; Jones MK; Lazzara MJ; Bouton AH
    Am J Cancer Res; 2021; 11(10):4768-4787. PubMed ID: 34765292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. v-Crk induces Rac-dependent membrane ruffling and cell migration in CAS-deficient embryonic fibroblasts.
    Sung BH; Yeo MG; Oh HJ; Song WK
    Mol Cells; 2008 Feb; 25(1):131-7. PubMed ID: 18319625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.